Read next
Health
Continuous Glucose Monitors Expand Beyond Diabetes Management
Medical device manufacturers secure regulatory approvals to offer continuous monitoring hardware to non-diabetic populations.
Health
Targeted Therapies Restructure Oncology Clinical Trial Pipelines
Pharmaceutical developers shift focus toward precision biomarkers, reducing late-stage trial attrition rates.
Health
GLP-1 Demand Surge Reshapes Pharmaceutical Contract Manufacturing
Unprecedented demand for metabolic therapeutics forces pharmaceutical firms to secure limited global fill-finish capacity.
Health
Decentralized Clinical Trials Leverage Wearable Diagnostics to Reduce Phase III Costs
Pharmaceutical developers adopt continuous physiological monitoring to lower patient dropout rates and accelerate drug approval timelines.
Health
Pharmaceutical Giants Expand GLP-1 Supply Lines to Meet Global Demand
Drugmakers commit billions to contract manufacturing agreements as metabolic therapies face chronic worldwide shortages.
Health
Clinical Trial Decentralization Drives Efficiency Gains in Phase III Oncology Studies
Digital monitoring tools and local laboratory partnerships are cutting trial completion times and reducing patient drop-out rates.